Dr. Mohammed Salhab
Claim this profileParker Adventist Hospital
Area of expertise
Non-Small Cell Lung Cancer
Mohammed Salhab has run 1 trial for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Lung Cancer
Mohammed Salhab has run 1 trial for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Parker Adventist Hospital
Porter Adventist Hospital
Clinical Trials Mohammed Salhab is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting
2 awards
Phase 3
2 criteria
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
More about Mohammed Salhab
Clinical Trial Related
3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Mohammed Salhab has experience with
- Gemcitabine Hydrochloride
- Paclitaxel
- Carboplatin
- Pembrolizumab
- Pemetrexed Disodium
- Docetaxel
Breakdown of trials Mohammed Salhab has run
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Bladder Cancer
Urothelial Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohammed Salhab specialize in?
Mohammed Salhab focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Mohammed Salhab currently recruiting for clinical trials?
Yes, Mohammed Salhab is currently recruiting for 3 clinical trials in Parker Colorado. If you're interested in participating, you should apply.
Are there any treatments that Mohammed Salhab has studied deeply?
Yes, Mohammed Salhab has studied treatments such as Gemcitabine Hydrochloride, Paclitaxel, Carboplatin.
What is the best way to schedule an appointment with Mohammed Salhab?
Apply for one of the trials that Mohammed Salhab is conducting.
What is the office address of Mohammed Salhab?
The office of Mohammed Salhab is located at: Parker Adventist Hospital, Parker, Colorado 80138 United States. This is the address for their practice at the Parker Adventist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.